Boston Scientific Corporation (NYSE:BSX) Q1 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Boston Scientific First Quarter 2025 Earnings Call. Please note this event is being recorded.
Boston Scientific Corp (BSX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Aubrey Capital Management Andrew Dalrymple And Barry Mccorkell | 44,000 | $4,438,492 | -14% | 1.78% |
| 2. | Running Oak Capital Seth Cogswell | 2,254 | $227,384 | -99% | 0.03% |
| 3. | Sivik Global Healthcare Krishen Sud | 100,000 | $10,088 | -10% | 5.45% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $90.29 | 50 | Officer | 148,168 | 2024-12-03 | Filing | |
| $41.98 | 25,000 | Director | 25,000 | 2021-11-15 | Filing | |
| $27.50 | 13 | Director | 32,337 | 2017-09-01 | Filing | |
| $27.80 | 30 | Director | 32,324 | 2017-06-16 | Filing | |
| $25.52 | 29 | Director | 32,294 | 2017-04-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $95.09 | 4,826 | Officer | 36,193 | 2025-04-21 | Filing | |
| $100.01 | 164,442 | Officer, Director | 1,594,530 | 2025-04-01 | Filing | |
| $100.85 | 4,826 | Officer | 41,019 | 2025-03-21 | Filing | |
| $104.63 | 482 | Officer | 432 | 2025-03-04 | Filing | |
| $104.97 | 7,149 | Officer | 914 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,495,130 | $352,588,714 | 0.25% | |
| 2. | 2,796,444 | $282,105,256 | 0.26% | |
| 3. | 2,485,696 | $250,757,012 | 0.42% | |
| 4. | 2,389,578 | $241,060,627 | 0.47% | |
| 5. | 1,855,240 | $187,824,498 | 0.33% |
News See All
12 Best Stocks Under $100 to Buy According to Hedge Funds
On April 21, Chris Davis of Davis Advisors appeared on 'The Exchange' on CNBC to talk about selectivity in today’s market.
10 Best Low Volatility Stocks to Buy Now
The US stock market experienced a turbulent first quarter of 2025, marked by increased volatility and negative returns across the major indices.
10 Innovative Healthcare Stocks to Watch in 2025
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023.
Boston Scientific Corporation (BSX): A Bull Case Theory
We came across a bullish thesis on Boston Scientific Corporation (BSX) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BSX.
10 Best Healthcare Stocks to Buy According to Billionaires
Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and AI.
Top 10 Stocks to Buy According to Marshall Wace LLP
Marshall Wace LLP is a prominent British hedge fund established in 1997 by Paul Marshall and Ian Wace. Headquartered in London, the firm has grown to become one of the world's leading hedge funds.
Israel Englander’s Stock Portfolio: Top 10 Stocks to Invest in
Millennium Management is a globally recognized investment firm specializing in multi-strategy hedge fund offerings.
Solid Company Fundamentals Lifted Boston Scientific Corporation (BSX)
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.
10 Best Momentum Stocks to Buy According to Hedge Funds
In the fast-paced world of investing, momentum is a force that can propel portfolios to new heights—or leave them vulnerable to abrupt reversals.
Billionaire Hedge Funds
